Published copy with acknowledgements.pdf (239.86 kB)

Automating decentralized manufacturing of cell and gene therapy products.

Download (239.86 kB)
journal contribution
posted on 15.12.2016, 14:33 by Richard Harrison, Qasim A. Rafiq, Nick Medcalf
Decentralized, or redistributed manufacture, is likely to be the manufacturing approach of choice for some cell- and gene-based therapies, in particular, personalized therapies. Such an approach will ultimately depend on the business model and will take into account the regulatory and supply chain factors. Advances in technology and integration of automated production platforms have demonstrated the potential for decentralized manufacturing, however there is a need to extend the scope of automation across the entire process including the cell isolation, distribution, tracking, administration, quality management systems and development of automated analytical techniques to facilitate real-time release. For decentralized manufacture to be successfully integrated for cell and gene therapy production, lessons from other accepted healthcare-associated models of manufacture can provide useful insights and perspectives to make informed decisions. Such models share similar characteristics to decentralized manufacture in that they are patient-specific and have a limited time-frame for administration. These existing approaches, which have successfully incorporated aspects of automation, can provide a blueprint for success and may expedite the decentralization of patient-specific cell and gene therapy manufacture.

Funding

This work has received funding from the EPSRC under Grant EPIM017559/1 as part of the project “Cell Microfactories: A Feasibility Study in the Redistributed Manufacture of Cell-Based Therapeutics”. The work has also received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 667932.

History

School

  • Mechanical, Electrical and Manufacturing Engineering

Published in

Cell & Gene Therapy Insights

Volume

2

Issue

1

Pages

115-120

Citation

HARRISON, R.P., RAFIQ, Q.A. and MEDCALF, N., 2016. Automating decentralized manufacturing of cell and gene therapy products. Cell & Gene Therapy Insights, 2(1), pp. 115-120.

Publisher

© The Authors. Published by BioInsights Publishing

Version

VoR (Version of Record)

Publisher statement

This work is made available according to the conditions of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) licence. Full details of this licence are available at: https://creativecommons.org/licenses/by-nc-nd/4.0/

Publication date

2016-03-21

Copyright date

2016

Notes

This is an Open Access Article. It is published by BioInsights Publishing under the Creative Commons Attribution 4.0 NonCommercial – NoDerivatives Licence (CC BY-NC-ND). Full details of this licence are available at: http://creativecommons.org/licenses/by-nc-nd/4.0/

ISSN

2059-7800

Language

en

Exports

Logo branding

Keywords

Exports